August 1, 2018
This Week's Issue Sponsored by:
Emerging Pharma: Who is Rising to the Top?
By: Patricia Van Arnum, DCAT Editorial Director

Emerging pharma companies are an important source of product innovation for the pharmaceutical industry, so which companies are making the mark? DCAT Value Chain Insights takes an inside look.  
For new molecular entities approved by the US Food and Drug Administration thus far in 2018, more than 60% have originated from small-to-mid-sized, innovator pharmaceutical companies, continuing a recent trend. DCAT Value Chain Insights examines key recent approvals. 
Drug Pricing: What is Brewing in Policy Debates?
By: Patricia Van Arnum, DCAT Editorial Director

The Pharmaceutical Research and Manufacturers of America (PhRMA) has released a new policy position that delinks supply-chain payments as a means to improve patient affordability. The policy is in response to an earlier blueprint issued by the Department of Health and Human Services to address drug pricing in the US.  

Calling it a “bold new policy position,” PhRMA is advocating for reforms that would prevent pharmacy benefit managers and other entities in the supply chain from having their compensation calculated as a percent of the list price of a medicine and instead is advocating for a fee based on the value their services provide.  DCAT Value Chain Insights takes an inside look. 
VCI Headliners: Top Industry News
There will be no issue of  DCAT Value Chain Insights  on August 8 . The next issue of  DCAT Value Chain Insights   will be August 15.
About the Editor
Patricia Van Arnum has more than 20 years of experience as a business and science editor, covering the chemical, pharmaceutical, biopharmaceutical, and fine-chemicals industries. Ms. Van Arnum was Executive Editor of Pharmaceutical Technology from 2006 to 2014 and Executive Editor of ICIS Chemical Business and Chemical Market Reporter ( CMR ) from 1995 to 2005.
DCAT Value Chain Insights is produced and distributed by the Drug, Chemical and Associated Technologies Association .
To learn more, please visit .